Injectable Bioactive Composites vs RMGI for Proximal Cavities in Primary Molars

This randomized clinical trial aims to evaluate and compare the clinical performance of injectable bioactive composite (Beautifil Flow Plus X, Shofu) versus Resin Modified Glass Ionomer (RMGI) in restoring proximal cavities (Class II) in primary molars of children aged 3-8 years over a 12-month follow-up period, using revised FDI criteria.

NCT Number	NCT07561216
Lead Sponsor	Cairo University
Conditions	Dental Caries
Enrollment	50 participants
Start Date	2026-05
Primary Completion	2027-06 (estimated)
Study Completion	2027-09 (estimated)
Updated on ClinicalTrials.gov	2026-05-01